Office-based strategies for the management of obesity

Am Fam Physician. 2010 Jun 15;81(12):1449-56 ; quiz 1429.

Abstract

Roughly two thirds of U.S. adults are overweight or obese. Obesity increases the risk of hypertension, type 2 diabetes mellitus, hyperlipidemia, heart disease, pulmonary disease, hepatobiliary disease, cancer, and a number of psychosocial complications. Physicians often feel unprepared to handle this important problem. Practical office-based strategies include: (1) making recommendations for assisted self-management, including guidance on popular diets, (2) advising patients about commercial weight-loss programs, (3) advising patients about and prescribing medications, (4) recommending bariatric surgery, and (5) supplementing these strategies with counseling about lifestyle changes using a systematic approach. Family physicians should provide basic information about the effectiveness and safety of popular diets and commercial weight-loss programs, and refer patients to appropriate information sources. Sibutramine and orlistat, the only medications currently approved for the long-term treatment of obesity, should only be prescribed in combination with lifestyle changes. Bariatric surgery is an option for adults with a body mass index of 40 kg per m2 or higher, or for those with a body mass index of 35 kg per m2 or higher who have obesity-related comorbidities such as type 2 diabetes. The five A's behavioral counseling paradigm (ask, advise, assess, assist, and arrange) can be used as the basis for a systematic, practical approach to the management of obesity that incorporates evidence for managing common obesity-related behaviors.

Publication types

  • Review

MeSH terms

  • Adult
  • Anti-Obesity Agents / therapeutic use
  • Bariatric Surgery
  • Body Mass Index
  • Child
  • Counseling
  • Cyclobutanes / therapeutic use
  • Diet, Reducing
  • Female
  • Humans
  • Lactones / therapeutic use
  • Male
  • Obesity / complications
  • Obesity / diagnosis
  • Obesity / diet therapy
  • Obesity / drug therapy
  • Obesity / therapy*
  • Orlistat
  • Risk Factors

Substances

  • Anti-Obesity Agents
  • Cyclobutanes
  • Lactones
  • Orlistat
  • sibutramine